chr17-7675089-G-A
Variant summary
The NM_000546.6(TP53):c.523C>T (p.Arg175Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00000681 (AC=11) in the gnomAD database across 1,614,206 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000207. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★★★). ClinVar reports functional evidence for this variant: "SCV000833097: Experimental studies have shown that this missense change does not substantially affect TP53 function (PMID:12826609, 29979965, 30224644, 33245408).". A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R175H: Pathogenic (ClinVar VariationId 12374, 3 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R175?: Uncertain_significance (ClinVar VariationId 2687679, 0 stars); p.R175= (synonymous): Benign/Likely_benign (ClinVar VariationId 1527986, 2 stars) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). The variant position is a cancer hotspot (cancerhotspots.org): 570 samples carry this exact amino acid change out of 2850 samples with a variant at this residue. This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000546.6 missense
Scores
Clinical Significance
Conservation
Publications
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- Li-Fraumeni syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
- Li-Fraumeni syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- adrenocortical carcinoma, hereditaryInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- bone marrow failure syndrome 5Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- colorectal cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- choroid plexus carcinomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 10 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000833097: Experimental studies have shown that this missense change does not substantially affect TP53 function (PMID: 12826609, 29979965, 30224644, 33245408). | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 38 pathogenic, 5 benign (OR vs. background: 35.0). | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R175H: Pathogenic (ClinVar VariationId 12374, 3 stars); Other variants at the same amino acid residue (not pathogenic): p.R175?: Uncertain_significance (ClinVar VariationId 2687679, 0 stars); p.R175= (synonymous): Benign/Likely_benign (ClinVar VariationId 1527986, 2 stars) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000546.6. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TP53 | MANE Select | c.523C>T p.Arg175Cys | missense | Exon 5 of 11 | Prot: NP_000537.3 | |
TP53 | c.523C>T p.Arg175Cys | missense | Exon 5 of 11 | Prot: NP_001119584.1 | ||
TP53 | c.523C>T p.Arg175Cys | missense | Exon 6 of 12 | Prot: NP_001394191.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TP53 | TSL:1MANE Select | c.523C>T p.Arg175Cys | missense | Exon 5 of 11 | Prot: ENSP00000269305.4 UniProt: | |
TP53 | TSL:1 | c.523C>T p.Arg175Cys | missense | Exon 5 of 11 | Prot: ENSP00000391478.2 UniProt: | |
TP53 | TSL:1 | c.406C>T p.Arg136Cys | missense | Exon 4 of 10 | Prot: ENSP00000478219.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000197 | AC:3 | Hom:0 | AN:152204 | Cov:33 |
GnomAD2 exomes | AF: 0.0000159 | AC:4 | AN:251284 | ||
GnomAD4 exome | AF: 0.00000547 | AC:8 | Hom:0 | AN:1461884 | Cov:35 |
GnomAD4 genome | AF: 0.0000197 | AC:3 | Hom:0 | AN:152322 | Cov:33 |
TOPMed (Bravo) | AF: 0.00000378 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:0 | AN:51978 | |
Local & regional cohorts 1 source | |||||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.0000160 | AC:2 | Hom:0 | AN:122282 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000312 * | 3 | 9622 | 0.00 * | 0 | 10428 |
BipEx | 0.0000352 | 1 | 28420 | 0.00 | 0 | 28844 |
Epi25 | 0.00 | 0 | 41958 | 0.0000150 | 1 | 66888 |
SCHEMA | 0.0000102 | 1 | 98004 | 0.00000620 | 1 | 161300 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Pathogenic | 0.92 | |
BayesDel_addAF | Pathogenic | 0.42 | D |
BayesDel_noAF | Pathogenic | 0.54 | |
CADD | Pathogenic | 29 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.86 | D |
Eigen | Uncertain | 0.41 | |
Eigen_PC | Uncertain | 0.29 | |
FATHMM_MKL | Uncertain | 0.97 | D |
FuncVEP CTI | Pathogenic | 0.92 | |
GPN-Star LLR | N/A | -8.3 | |
GPN-Star score | N/A | 8.3 | |
LIST_S2 | Uncertain | 0.95 | D |
M_CAP | Pathogenic | 0.88 | D |
MetaRNN | Pathogenic | 0.99 | D |
MetaSVM | Pathogenic | 1.1 | D |
Mutation Taster | N/A | 0/100 | disease causing |
MutationAssessor | Pathogenic | 2.9 | M |
PhyloP100 | Uncertain | 4.0 | |
popEVE | Benign | -3.6 | |
PrimateAI | Uncertain | 0.71 | T |
PromoterAI | N/A | -0.022 | Neutral |
PROVEAN | Pathogenic | -7.7 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.1 | |
REVEL | Pathogenic | 0.83 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.95 | |
VESM-3B | Benign | -11 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.030 | |
SpliceAI score (max) | Benign | 0.11 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- TP53
- Score
- -0.759